Madison Al Saadi
Analyst
B. Riley Securities
Equibles does not estimate personal net worth.
About Madison Al Saadi
Madison Al Saadi is recorded as Analyst at B. Riley Securities. Madison Al Saadi has spoken on 3 earnings calls across 2 companies, most recently for Wave Life Sciences, Inc. on October 27, 2026. Those appearances were for Wave Life Sciences, Inc. (WVE) and Axsome Therapeutics, Inc. (AXSM). The companies whose calls Madison Al Saadi spoke on are classified in the Healthcare sector.
Madison Al Saadi on recent calls
“Maybe on the 2Q revenue, how much of that reflects any channel stocking versus dispensed demand? If you could just help – sorry if I missed it.”
“It's nice to see you're adding MRI-PDFL to your planned Phase II Obesity trial. I'm just wondering what is the treatment delta you are expecting to get there, just recognizing I think that model of therapy, single glutide, gets around 30% to 40%.”
Affiliation history
-
B. Riley Securities
Analyst
Transcript header (unverified)
Current